ASTS
AST SpaceMobile, Inc.
ASTS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CLVT
Clarivate Plc
CLVT has a slight edge over ASTS overall, supported by lower modeled downside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CLVT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Healthy | |
| Weak |
CLVT's cash flow is currently healthy, but its revenue, profitability and balance sheet are under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CLVT PE Valuation
CLVT has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CLVT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CLVT's earnings and revenue to decline, though with profitability improving.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
CLVT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.62 | — |
| Q3 2026 | -$0.61 | -$0.04 |
| Q2 2026 | -$0.52 | +$0.10 |
| Q1 2026 | -$0.21 | +$0.76 |
| Q4 2025 | -$0.30 | +$0.66 |
| Q3 2025 | -$0.57 | +$1.41 |
| Q2 2025 | -$0.62 | +$1.28 |
| Q1 2025 | -$0.97 | +$0.68 |
| Q4 2024 | -$0.96 | +$0.51 |
CLVT has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over CLVT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CLVT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $481.6M | -23% |
| Q2 2026 | $587.3M | -5.5% |
| Q1 2026 | $585.5M | -1.4% |
| Q4 2025 | $617M | -6.9% |
| Q3 2025 | $623.1M | +0.1% |
| Q2 2025 | $621.4M | -4.4% |
| Q1 2025 | $593.7M | -4.4% |
| Q4 2024 | $663M | -3% |
CLVT's revenue has slid since its 2022 peak: $482M last quarter, down 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.3% | +1.3 points |
| Q2 2026 | -34% | -35 points |
| Q1 2026 | 5.2% | +8.7 points |
| Q4 2025 | 6.7% | +16 points |
| Q3 2025 | 7.1% | +3.6 points |
| Q2 2025 | 1.1% | +38 points |
| Q1 2025 | -3.5% | -4.3 points |
| Q4 2024 | -9.4% | +106 points |
CLVT has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CLVT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $110.2M | -4.6% |
| Q2 2026 | $44M | -13% |
| Q1 2026 | $78.9M | -28% |
| Q4 2025 | $89.2M | +51% |
| Q3 2025 | $115.5M | -8.6% |
| Q2 2025 | $50.3M | -17% |
| Q1 2025 | $110.3M | -1.3% |
| Q4 2024 | $59.1M | -53% |
CLVT has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CLVT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +300K shares |
| 1 year | -4.3% | -28.6M shares |
| 3 years | -4.7% | -31.2M shares |
| 5 years | +4.7% | +28.6M shares |
| Available history | +86% | +297M shares |
CLVT has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $18.1M |
| Q4 2025 | $75M |
| Q3 2025 | $50M |
| Q2 2025 | $49.5M |
| Q1 2025 | $50M |
| Q4 2024 | $100M |
CLVT spent $93M buying back its own shares over the past year, down 63% from the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CLVT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.1x | High |
| Q2 2026 | 6.0x | High |
| Q1 2026 | 4.6x | High |
| Q4 2025 | 4.9x | High |
| Q3 2025 | 5.7x | High |
| Q2 2025 | 6.1x | High |
| Q1 2025 | 9.7x | High |
| Q4 2024 | 9.4x | High |
CLVT's net debt is about 6.1 years of its operating earnings (EBITDA), up from 5.7 years a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CLVT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.8 | Neutral |
| Stochastic | 66.9 | Neutral |
CLVT's weekly RSI is 54 (neutral) and its Stochastic is 67 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CLVT PE vs Technology Sector
| Metric | CLVT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CLVT has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
CLVT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.85 | 24% above |
| 20 week MA | $1.99 | 16% above |
| 50 week MA | $2.38 | 3.4% below |
| 100 week MA | $3.29 | 30% below |
| 200 week MA | $5.46 | 58% below |
CLVT has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
CLVT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.0 | $30.1 | +77% |
| 2021 | $30.1 | $24.7 | -18% |
| 2022 | $24.7 | $8.16 | -67% |
| 2023 | $8.16 | $9.26 | +13% |
| 2024 | $9.26 | $5.12 | -45% |
| 2025 | $5.12 | $3.50 | -32% |
| 2026 YTD | $3.50 | $2.30 | -34% |
CLVT has the edge over ASTS on returns for 2026, with the stronger performance.